Oxnard-based medical cannabis and drug delivery company Cure Pharmaceutical announced an all-stock deal April 1 to acquire Santa Monica seed-stage firm Chemistry Holdings. Cure said it would receive $2 million from Chemistry Holdings, in exchange for convertible notes, which would turn into around 600,000 shares of Cure stock at $3.34 per share if the deal…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
